Comparison of CDB-2914 Versus Placebo in the Prevention of Follicular Rupture Post-luteinizing Hormone (LH) Surge
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Evaluation of the effect of a single dose of CDB-2914, as compared to placebo, administered
after the onset of the LH surge on the outcome of the leading ovary follicle:
- echographic follicle rupture
- inhibition of follicle rupture
- luteal phase progesterone levels
- anovulatory progesterone levels